{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:56:12Z","timestamp":1773982572834,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T00:00:00Z","timestamp":1296086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016319","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T22:04:12Z","timestamp":1296165852000},"page":"e16319","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["HNF4alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension"],"prefix":"10.1371","volume":"6","author":[{"given":"Monika","family":"Niehof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Borlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00869843","article-title":"The pathophysiology of Sandimmune (cyclosporine) in man and animals.","volume":"4","author":"J Mason","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ajh\/4.5.468","article-title":"Mechanism of cyclosporine-induced hypertension.","volume":"4","author":"RG Luke","year":"1991","journal-title":"Am J Hypertens"},{"key":"ref3","first-page":"395","article-title":"Hypertension in transplant recipients.","volume":"10","author":"DR Singer","year":"1996","journal-title":"J Hum Hypertens"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.","volume":"4","author":"O Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007893.pub2","article-title":"Effect of cyclosporine on blood pressure.","volume":"CD007893","author":"N Robert","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1161\/01.CIR.101.24.2863","article-title":"Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.","volume":"101","author":"JA Hill","year":"2000","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.HYP.0000085195.38870.44","article-title":"Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.","volume":"42","author":"A Nishiyama","year":"2003","journal-title":"Hypertension"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.jhh.1000709","article-title":"Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates.","volume":"12","author":"B Bartholomeusz","year":"1998","journal-title":"J Hum Hypertens"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1111\/j.1440-1681.1995.tb02984.x","article-title":"Cyclosporine A-induced hypertension in SHR and WKY: role of the sympatho-adrenal system.","volume":"Physiol","author":"HF Grobecker","year":"1995","journal-title":"Clin Exp Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-1681.1994.tb02502.x","article-title":"Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat.","volume":"21","author":"KA Rolls","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.HYP.18.4.458","article-title":"Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats.","volume":"18","author":"BJ Morgan","year":"1991","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3565(25)20565-1","article-title":"Systemic vascular effects of cyclosporin A treatment in normotensive rats.","volume":"259","author":"A Rego","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","first-page":"H1791","article-title":"Dose-dependent effect of cyclosporin on renal arterial resistance in dogs.","volume":"261","author":"M Carrier","year":"1991","journal-title":"Am J Physiol"},{"key":"ref14","first-page":"827","article-title":"[Effect of therapeutic doses of cyclosporine injected into the renal and femoral arteries in dogs].","volume":"45","author":"F Tronc","year":"1991","journal-title":"Ann Chir"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00007890-199001000-00032","article-title":"Cyclosporine-induced hypertension in sheep. The role of thromboxanes.","volume":"49","author":"JJ Tresham","year":"1990","journal-title":"Transplantation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004872-199301000-00011","article-title":"Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.","volume":"11","author":"JP Clozel","year":"1993","journal-title":"J Hypertens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0012.2005.00357.x","article-title":"Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.","volume":"19","author":"RL Cauduro","year":"2005","journal-title":"Clin Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1389200023337964","article-title":"Interaction of cyclosporine A and the renin-angiotensin system; new perspectives.","volume":"3","author":"M Lassila","year":"2002","journal-title":"Curr Drug Metab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001573-199707000-00005","article-title":"Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine.","volume":"12","author":"HO Ventura","year":"1997","journal-title":"Curr Opin Cardiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00029330-200806010-00005","article-title":"Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.","volume":"121","author":"MH Shang","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"ref21","first-page":"350","article-title":"Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.","volume":"41","author":"BD Edwards","year":"1994","journal-title":"Clin Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00007890-199310000-00022","article-title":"Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation.","volume":"56","author":"J Julien","year":"1993","journal-title":"Transplantation"},{"key":"ref23","first-page":"209","article-title":"Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group.","volume":"15","author":"C Letizia","year":"1995","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.2042-7158.1990.tb06614.x","article-title":"Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats.","volume":"42","author":"A Erman","year":"1990","journal-title":"J Pharm Pharmacol"},{"key":"ref25","first-page":"7","article-title":"From bedside to bench drug-induced tubulointerstitial disease cyclosporine nephropathy study from models of cultured renal epithelial cells.","volume":"30","author":"MS Wu","year":"2007","journal-title":"Chang Gung Med J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1046\/j.1523-1755.1999.00481.x","article-title":"Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells.","volume":"55","author":"PV Avdonin","year":"1999","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005344-199507000-00011","article-title":"Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.","volume":"26","author":"V Regitz-Zagrosek","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref28","first-page":"341","article-title":"Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats.","volume":"248","author":"J Iwai","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy.","volume":"33","author":"BD Myers","year":"1988","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90497-9","article-title":"Suppression of plasma renin activity by cyclosporine.","volume":"83","author":"JP Bantle","year":"1987","journal-title":"Am J Med"},{"key":"ref31","first-page":"S28","article-title":"Cyclosporine and the renin-angiotensin system.","volume":"Int","author":"J Mason","year":"1991","journal-title":"Kidney"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000020664","article-title":"Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats.","volume":"8","author":"C Ramirez","year":"2000","journal-title":"Exp Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ki.1995.312","article-title":"Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.","volume":"48","author":"BA Young","year":"1995","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","article-title":"Cyclosporine nephrotoxicity.","volume":"36","author":"A Busauschina","year":"2004","journal-title":"Transplant Proc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1524-6175.2007.5998.x","article-title":"Hypertension treatment guidelines: is it time for an update?","volume":"9","author":"M Moser","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.","volume":"17","author":"G Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e4662","DOI":"10.1371\/journal.pone.0004662","article-title":"HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus.","volume":"4","author":"J Borlak","year":"2009","journal-title":"PLoS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.274.49.34605","article-title":"Regulated Expression of Human Angiotensinogen Gene by Hepatocyte Nuclear Factor 4 and Chicken Ovalbumin Upstream Promoter-Transcription Factor.","volume":"274","author":"K Yanai","year":"1999","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1074\/jbc.M310577200","article-title":"Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.","volume":"279","author":"Y Shimamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2125.1984.tb02338.x","article-title":"Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.","volume":"17","author":"C Richer","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/toxsci\/kfp216","article-title":"Toxicogenomics applied to cultures of human hepatocytes enabled an identification of novel petasites hybridus extracts for the treatment of migraine with improved hepatobiliary safety.","volume":"112","author":"N Anderson","year":"2009","journal-title":"Toxicol Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2199-10-68","article-title":"Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier.","volume":"10","author":"M Niehof","year":"2009","journal-title":"BMC Mol Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1111\/j.1440-1681.1996.tb02816.x","article-title":"Human type-1 angiotensin II (AT1) receptor gene structure and function.","volume":"Physiol","author":"KM Curnow","year":"1996","journal-title":"Clin Exp Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1043-2760(02)00038-3","article-title":"Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor.","volume":"14","author":"TS Elton","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1124\/mol.104.001677","article-title":"A novel computational approach for the prediction of networked transcription factors of aryl hydrocarbon-receptor-regulated genes.","volume":"66","author":"A Kel","year":"2004","journal-title":"Mol Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3349\/ymj.2004.45.6.1004","article-title":"Chronic cyclosporine nephrotoxicity: new insights and preventive strategies.","volume":"45","author":"C Li","year":"2004","journal-title":"Yonsei Med J"},{"key":"ref47","first-page":"173","article-title":"Localization of PDGF-BB in the juxtaglomerular cells of cyclosporin-treated rats.","volume":"3","author":"M Shehata","year":"1995","journal-title":"Exp Nephrol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1681\/ASN.V641186","article-title":"Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.","volume":"6","author":"RH Pichler","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-199508000-00005","article-title":"Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.","volume":"60","author":"G Wolf","year":"1995","journal-title":"Transplantation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1006\/jmcc.2002.2075","article-title":"Local cardiac renin-angiotensin system: hypertension and cardiac failure.","volume":"34","author":"J Varagic","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature05097","article-title":"Calcineurin\/NFAT signalling regulates pancreatic beta-cell growth and function.","volume":"443","author":"JJ Heit","year":"2006","journal-title":"Nature"},{"key":"ref52","first-page":"99","article-title":"Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation.","volume":"14","author":"M Jamaluddin","year":"2000","journal-title":"Mol Endocrinol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2741\/3289","article-title":"The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor.","volume":"14","author":"ER Porrello","year":"2009","journal-title":"Front Biosci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cardiores.2006.09.006","article-title":"ACE2 of the heart: From angiotensin I to angiotensin (1-7).","volume":"73","author":"S Keidar","year":"2007","journal-title":"Cardiovasc Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0b013e3282f945c2","article-title":"New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.","volume":"17","author":"D Batlle","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology.","volume":"13","author":"GY Oudit","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1592\/phco.30.2.195","article-title":"Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.","volume":"30","author":"JP Bai","year":"2010","journal-title":"Pharmacotherapy"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:21:34Z","timestamp":1740896494000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016319"}},"subtitle":[],"editor":[{"given":"Marcelo","family":"Bonini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016319","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,27]]}}}